SALT LAKE CITY, Feb. 16, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN - News) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the RBC Capital Markets’ Healthcare Conference, at 2:35 p.m. Eastern on March 2, 2010, at the New York Palace Hotel in New York City.
